Literature DB >> 16771905

Epigenetics of lung cancer.

Rayleen V Bowman1, Ian A Yang, Annalese B T Semmler, Kwun M Fong.   

Abstract

Epigenetics is the study of heritable changes in gene expression that occur without changes in DNA sequence. It has a role in determining when and where a gene is expressed during development. Perhaps the most well known epigenetic mechanism is DNA methylation whereby cytosines at position 5 in CpG dinucleotides are methylated. Histone modification is another form of epigenetic control, which is quite complex and diverse. Histones and DNA make up the nucleosome which is the structural unit of chromatin which are involved in packaging DNA. Apart from the crucial role epigenetics plays in embryonic development, transcription, chromatin structure, X chromosome inactivation and genomic imprinting, its role in an increasing number of human diseases is more and more recognized. These diseases include cancer, and lung cancer in particular has been increasingly studied for the potential biological role of epigenetic changes with the promise of better and novel diagnostic and therapeutic tools.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16771905     DOI: 10.1111/j.1440-1843.2006.00859.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  12 in total

Review 1.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Authors:  Satish Kalari; Gerd P Pfeifer
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

2.  Gene silencing associated with SWI/SNF complex loss during NSCLC development.

Authors:  Shujie Song; Vonn Walter; Mehmet Karaca; Ying Li; Christopher S Bartlett; Dominic J Smiraglia; Daniel Serber; Christopher D Sproul; Christoph Plass; Jiren Zhang; D Neil Hayes; Yanfang Zheng; Bernard E Weissman
Journal:  Mol Cancer Res       Date:  2014-01-20       Impact factor: 5.852

3.  Sulforaphane epigenetically demethylates the CpG sites of the miR-9-3 promoter and reactivates miR-9-3 expression in human lung cancer A549 cells.

Authors:  Linbo Gao; David Cheng; Jie Yang; Renyi Wu; Wenji Li; Ah-Ng Kong
Journal:  J Nutr Biochem       Date:  2018-02-09       Impact factor: 6.048

4.  Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.

Authors:  Juan P de-Torres; David O Wilson; Pablo Sanchez-Salcedo; Joel L Weissfeld; Juan Berto; Arantzazu Campo; Ana B Alcaide; Marta García-Granero; Bartolome R Celli; Javier J Zulueta
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

Review 5.  Epigenetics in assisted reproductive technology.

Authors:  Yukiko Katagiri; Yukihiro Shibui; Koichi Nagao; Kazukiyo Miura; Mineto Morita
Journal:  Reprod Med Biol       Date:  2007-05-14

6.  DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients.

Authors:  Qinghua Feng; Stephen E Hawes; Joshua E Stern; Linda Wiens; Hiep Lu; Zhao Ming Dong; C Diana Jordan; Nancy B Kiviat; Hubert Vesselle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

7.  Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research.

Authors:  Antonello Punturieri; Eva Szabo; Thomas L Croxton; Steven D Shapiro; Steven M Dubinett
Journal:  J Natl Cancer Inst       Date:  2009-04-07       Impact factor: 13.506

8.  Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells.

Authors:  Samiha Mateen; Komal Raina; Chapla Agarwal; Daniel Chan; Rajesh Agarwal
Journal:  J Pharmacol Exp Ther       Date:  2013-03-05       Impact factor: 4.030

9.  Expression and methylation of mitochondrial transcription factor a in chronic obstructive pulmonary disease patients with lung cancer.

Authors:  Hong Peng; Min Yang; Zhi-yong Chen; Ping Chen; Cha-xiang Guan; Xu-dong Xiang; Shan Cai; Yan Chen; Xiang Fang
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

Review 10.  Molecular profile of lung cancer in never smokers.

Authors:  Janakiraman Subramanian; Ramaswamy Govindan
Journal:  EJC Suppl       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.